Northern Trust’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Sell |
139,074
-289,050
| -68% | -$1.16M | ﹤0.01% | 3616 |
|
|
2025
Q1 | $390K | Sell |
428,124
-22,640
| -5% | -$20.6K | ﹤0.01% | 3674 |
|
|
2024
Q4 | $1.25M | Buy |
450,764
+11,919
| +3% | +$33K | ﹤0.01% | 3288 |
|
|
2024
Q3 | $2.3M | Buy |
438,845
+27,469
| +7% | +$144K | ﹤0.01% | 2922 |
|
|
2024
Q2 | $1.83M | Sell |
411,376
-8,503
| -2% | -$37.9K | ﹤0.01% | 2938 |
|
|
2024
Q1 | $3.22M | Sell |
419,879
-4,828
| -1% | -$37K | ﹤0.01% | 2735 |
|
|
2023
Q4 | $1.81M | Buy |
424,707
+90,060
| +27% | +$384K | ﹤0.01% | 3051 |
|
|
2023
Q3 | $1.41M | Buy |
334,647
+34,264
| +11% | +$144K | ﹤0.01% | 3125 |
|
|
2023
Q2 | $1.67M | Buy |
300,383
+254,501
| +555% | +$1.42M | ﹤0.01% | 3109 |
|
|
2023
Q1 | $263K | Sell |
45,882
-61
| -0.1% | -$350 | ﹤0.01% | 3731 |
|
|
2022
Q4 | $48.2K | Buy |
45,943
+5,639
| +14% | +$5.92K | ﹤0.01% | 4294 |
|
|
2022
Q3 | $108K | Sell |
40,304
-6,686
| -14% | -$17.9K | ﹤0.01% | 4088 |
|
|
2022
Q2 | $224K | Sell |
46,990
-66,833
| -59% | -$319K | ﹤0.01% | 3873 |
|
|
2022
Q1 | $466K | Sell |
113,823
-6,939
| -6% | -$28.4K | ﹤0.01% | 3766 |
|
|
2021
Q4 | $823K | Buy |
120,762
+4,661
| +4% | +$31.8K | ﹤0.01% | 3615 |
|
|
2021
Q3 | $1.35M | Sell |
116,101
-4,642
| -4% | -$53.8K | ﹤0.01% | 3445 |
|
|
2021
Q2 | $2.06M | Buy |
120,743
+5,274
| +5% | +$89.8K | ﹤0.01% | 3344 |
|
|
2021
Q1 | $2.29M | Buy |
115,469
+22,663
| +24% | +$449K | ﹤0.01% | 3169 |
|
|
2020
Q4 | $1.92M | Buy |
92,806
+42
| +0% | +$867 | ﹤0.01% | 3219 |
|
|
2020
Q3 | $2.44M | Buy |
+92,764
| New | +$2.44M | ﹤0.01% | 2961 |
|